Will Vale Face Manslaughter Charges After Brazilian Dam Disaster?

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Will Vale Face Manslaughter Charges After Brazilian Dam Disaster?

© andriano_cz / Getty Images

Vale S.A. (NYSE: VALE | VALE Price Prediction) shares were down handily on Tuesday after a Brazilian Senate committee announced that it recommends indicting Vale in a deadly dam collapse that occurred in late January. The committee also recommended the indictment of former Vale CEO Fabio Schvartsman and the current CFO Luciano Siani.

At the same time, the committee recommended that Congress pass a blanket ban on all tailings dams, with those already in place to be decommissioned in 10 years. Not to mention, it is the committee’s belief that taxes on mineral production should be raised and that a law should be passed to create additional types of environmental crimes.

Schvartsman stepped down as Vale’s CEO under pressure from prosecutors back in March. Siani, also targeted by the committee, continues to serve as CFO.

Although the committee’s recommendations are not binding, they could influence prosecutors who are continuing to investigate Vale and its executives for negligence regarding the disaster.

According to Reuters:

The committee is also seeking the indictment of Vale itself as a company, as well as dam stability auditor TÜV SÜD, for environmental damages and corporate responsibility for the actions of their employees in the disaster that killed nearly 250 people.

The 400-page report recommended a total of 16 indictments, including the two corporate ones and another 14 of individual executives and others, all of them for manslaughter and other crimes.

[nativounit]

Excluding Tuesday’s move, Vale has underperformed the broad markets with its stock up over 5% year to date. In the past 52 weeks, the stock is up closer to 11.5%.

Shares of Vale closed down over 4% at $13.30, with a 52-week range of $10.89 to $16.13. The consensus analyst price target of $14.71.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618